Holdings (Monthly)
Guide ↗
Invesco S&P SmallCap Health Care ETF
· Invesco Exchange-Traded Fund Trust II| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | N/A | Feb 2026 | 29,808,249 | $29.8M | 21.33% | STIV |
| 2 | Invesco Private Government Fund | N/A | Feb 2026 | 11,152,021 | $11.2M | 7.98% | STIV |
| 3 | Krystal Biotech, Inc. | 501147102 | Feb 2026 | 21,484 | $5.9M | 4.24% | EC |
| 4 | Glaukos Corp. | 377322102 | Feb 2026 | 47,811 | $5.8M | 4.12% | EC |
| 5 | PTC Therapeutics, Inc. | 69366J200 | Feb 2026 | 66,834 | $4.6M | 3.26% | EC |
| 6 | Protagonist Therapeutics, Inc. | 74366E102 | Feb 2026 | 48,917 | $4.5M | 3.22% | EC |
| 7 | Teleflex Inc. | 879369106 | Feb 2026 | 36,788 | $4.5M | 3.21% | EC |
| 8 | Alkermes PLC | G01767105 | Feb 2026 | 137,448 | $4.1M | 2.96% | EC |
| 9 | TransMedics Group, Inc. | 89377M109 | Feb 2026 | 28,448 | $4.1M | 2.96% | EC |
| 10 | RadNet, Inc. | 750491102 | Feb 2026 | 57,796 | $4.0M | 2.89% | EC |
| 11 | BrightSpring Health Services, Inc. | 10950A106 | Feb 2026 | 94,582 | $3.9M | 2.80% | EC |
| 12 | Merit Medical Systems, Inc. | 589889104 | Feb 2026 | 49,354 | $3.8M | 2.73% | EC |
| 13 | TG Therapeutics, Inc. | 88322Q108 | Feb 2026 | 113,180 | $3.4M | 2.44% | EC |
| 14 | Indivior Pharmaceuticals, Inc. | 45579U109 | Feb 2026 | 103,932 | $3.4M | 2.43% | EC |
| 15 | Ligand Pharmaceuticals Inc. | 53220K504 | Feb 2026 | 16,384 | $3.2M | 2.32% | EC |
| 16 | ICU Medical, Inc. | 44930G107 | Feb 2026 | 20,551 | $3.1M | 2.21% | EC |
| 17 | ADMA Biologics, Inc. | 000899104 | Feb 2026 | 198,116 | $3.1M | 2.21% | EC |
| 18 | Corcept Therapeutics Inc. | 218352102 | Feb 2026 | 77,929 | $2.8M | 1.99% | EC |
| 19 | Prestige Consumer Healthcare Inc. | 74112D101 | Feb 2026 | 40,026 | $2.8M | 1.98% | EC |
| 20 | Supernus Pharmaceuticals, Inc. | 868459108 | Feb 2026 | 47,731 | $2.6M | 1.87% | EC |
| 21 | Acadia Pharmaceuticals Inc. | 004225108 | Feb 2026 | 104,215 | $2.6M | 1.83% | EC |
| 22 | Integer Holdings Corp. | 45826H109 | Feb 2026 | 29,166 | $2.5M | 1.81% | EC |
| 23 | Waystar Holding Corp. | 946784105 | Feb 2026 | 95,555 | $2.5M | 1.75% | EC |
| 24 | Veracyte, Inc. | 92337F107 | Feb 2026 | 65,802 | $2.4M | 1.72% | EC |
| 25 | Concentra Group Holdings Parent, Inc. | 20603L102 | Feb 2026 | 99,223 | $2.4M | 1.70% | EC |
| 26 | Privia Health Group, Inc. | 74276R102 | Feb 2026 | 96,246 | $2.3M | 1.64% | EC |
| 27 | Catalyst Pharmaceuticals, Inc. | 14888U101 | Feb 2026 | 96,176 | $2.2M | 1.59% | EC |
| 28 | Neogen Corp. | 640491106 | Feb 2026 | 180,885 | $2.0M | 1.45% | EC |
| 29 | Amneal Pharmaceuticals, Inc. | 03168L105 | Feb 2026 | 141,309 | $2.0M | 1.40% | EC |
| 30 | LeMaitre Vascular, Inc. | 525558201 | Feb 2026 | 17,373 | $1.9M | 1.34% | EC |
| 31 | Acadia Healthcare Co., Inc. | 00404A109 | Feb 2026 | 76,798 | $1.8M | 1.29% | EC |
| 32 | Apellis Pharmaceuticals, Inc. | 03753U106 | Feb 2026 | 85,312 | $1.8M | 1.28% | EC |
| 33 | National HealthCare Corp. | 635906100 | Feb 2026 | 10,332 | $1.7M | 1.21% | EC |
| 34 | Organon & Co. | 68622V106 | Feb 2026 | 216,416 | $1.6M | 1.13% | EC |
| 35 | Addus HomeCare Corp. | 006739106 | Feb 2026 | 15,183 | $1.6M | 1.12% | EC |
| 36 | Omnicell, Inc. | 68213N109 | Feb 2026 | 37,356 | $1.5M | 1.10% | EC |
| 37 | Perrigo Co. PLC | G97822103 | Feb 2026 | 114,562 | $1.5M | 1.08% | EC |
| 38 | Vericel Corp. | 92346J108 | Feb 2026 | 42,099 | $1.5M | 1.07% | EC |
| 39 | Sarepta Therapeutics, Inc. | 803607100 | Feb 2026 | 87,227 | $1.5M | 1.05% | EC |
| 40 | Arcus Biosciences, Inc. | 03969F109 | Feb 2026 | 71,067 | $1.4M | 1.04% | EC |
| 41 | Tandem Diabetes Care, Inc. | 875372203 | Feb 2026 | 56,440 | $1.4M | 1.02% | EC |
| 42 | Inspire Medical Systems, Inc. | 457730109 | Feb 2026 | 22,010 | $1.4M | 1.02% | EC |
| 43 | Pediatrix Medical Group, Inc. | 58502B106 | Feb 2026 | 70,074 | $1.4M | 1.00% | EC |
| 44 | Select Medical Holdings Corp. | 81619Q105 | Feb 2026 | 91,731 | $1.4M | 0.98% | EC |
| 45 | Innoviva, Inc. | 45781M101 | Feb 2026 | 59,127 | $1.4M | 0.97% | EC |
| 46 | UFP Technologies, Inc. | 902673102 | Feb 2026 | 6,419 | $1.4M | 0.97% | EC |
| 47 | CorVel Corp. | 221006109 | Feb 2026 | 26,022 | $1.3M | 0.96% | EC |
| 48 | Artivion, Inc. | 228903100 | Feb 2026 | 34,704 | $1.3M | 0.96% | EC |
| 49 | QuidelOrtho Corp. | 219798105 | Feb 2026 | 56,548 | $1.3M | 0.92% | EC |
| 50 | Enovis Corp. | 194014502 | Feb 2026 | 47,605 | $1.2M | 0.87% | EC |
| 51 | CONMED Corp. | 207410101 | Feb 2026 | 25,779 | $1.2M | 0.85% | EC |
| 52 | Progyny, Inc. | 74340E103 | Feb 2026 | 66,741 | $1.2M | 0.84% | EC |
| 53 | ANI Pharmaceuticals, Inc. | 00182C103 | Feb 2026 | 14,965 | $1.1M | 0.79% | EC |
| 54 | Collegium Pharmaceutical, Inc. | 19459J104 | Feb 2026 | 26,314 | $1.1M | 0.78% | EC |
| 55 | NeoGenomics, Inc. | 64049M209 | Feb 2026 | 107,706 | $1.1M | 0.76% | EC |
| 56 | U.S. Physical Therapy, Inc. | 90337L108 | Feb 2026 | 12,657 | $1.1M | 0.75% | EC |
| 57 | Harmony Biosciences Holdings, Inc. | 413197104 | Feb 2026 | 33,081 | $944K | 0.68% | EC |
| 58 | Phibro Animal Health Corp. | 71742Q106 | Feb 2026 | 17,021 | $929K | 0.66% | EC |
| 59 | Azenta, Inc. | 114340102 | Feb 2026 | 33,961 | $916K | 0.66% | EC |
| 60 | Fortrea Holdings Inc. | 34965K107 | Feb 2026 | 76,916 | $825K | 0.59% | EC |
| 61 | STAAR Surgical Co. | 852312305 | Feb 2026 | 41,406 | $824K | 0.59% | EC |
| 62 | AdaptHealth Corp. | 00653Q102 | Feb 2026 | 89,332 | $817K | 0.58% | EC |
| 63 | BioLife Solutions, Inc. | 09062W204 | Feb 2026 | 32,464 | $786K | 0.56% | EC |
| 64 | Pacira Biosciences, Inc. | 695127100 | Feb 2026 | 35,812 | $785K | 0.56% | EC |
| 65 | Xencor, Inc. | 98401F105 | Feb 2026 | 59,443 | $759K | 0.54% | EC |
| 66 | Astrana Health, Inc. | 03763A207 | Feb 2026 | 35,914 | $730K | 0.52% | EC |
| 67 | Vir Biotechnology, Inc. | 92764N102 | Feb 2026 | 78,752 | $716K | 0.51% | EC |
| 68 | Certara, Inc. | 15687V109 | Feb 2026 | 99,437 | $704K | 0.50% | EC |
| 69 | Integra LifeSciences Holdings Corp. | 457985208 | Feb 2026 | 55,762 | $635K | 0.45% | EC |
| 70 | AMN Healthcare Services, Inc. | 001744101 | Feb 2026 | 31,977 | $623K | 0.45% | EC |
| 71 | Amphastar Pharmaceuticals, Inc. | 03209R103 | Feb 2026 | 29,453 | $596K | 0.43% | EC |
| 72 | Schrodinger, Inc. | 80810D103 | Feb 2026 | 46,712 | $563K | 0.40% | EC |
| 73 | Avanos Medical, Inc. | 05350V106 | Feb 2026 | 38,641 | $545K | 0.39% | EC |
| 74 | Embecta Corp. | 29082K105 | Feb 2026 | 48,684 | $499K | 0.36% | EC |
| 75 | HealthStream, Inc. | 42222N103 | Feb 2026 | 19,757 | $419K | 0.30% | EC |
| 76 | Cytek Biosciences, Inc. | 23285D109 | Feb 2026 | 91,537 | $410K | 0.29% | EC |
| 77 | Myriad Genetics, Inc. | 62855J104 | Feb 2026 | 77,594 | $358K | 0.26% | EC |
| 78 | Invesco Government & Agency Portfolio | 825252885 | Feb 2026 | 13,490 | $13K | 0.01% | STIV |
| 79 | OmniAb, Inc. | 68218J301 | Feb 2026 | 20,053 | $0 | 0.00% | EC |
| 80 | OmniAb, Inc. | 68218J202 | Feb 2026 | 20,053 | $0 | 0.00% | EC |